Apatinib for Advanced Biliary Carcinoma
NCT03427242
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Biliary Tract Neoplasms
Interventions
DRUG:
Apatinib
Sponsor
Fudan University